BCIC vs GILD · P/E 32, $92.3M cap vs P/E 18, rev $29.44B
BCP Investment Corp. (BCIC) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
BCP Investment Corp. (BCIC) is a asset management company listed on NASDAQ.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
BCIC does not have a complete income-statement cache yet.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
BCIC currently screens at market cap $92.3M and trailing P/E 32.4. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the BCIC and GILD stock pages for the full models.
Not investment advice.